Loading insider details...
Latest Form 4 (Aug 18, 2026): Grant/Award of 647 MDGL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 647 | n/a |
| May 4, 2026 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 25,255 | n/a |
| Feb 19, 2026 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 1,349 | n/a |
| Oct 20, 2025 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 21,721 | $3.43M |
| Jul 18, 2025 | JOHNSON & JOHNSON (JNJ) | Sale | 19,137 | $3.13M |
| May 5, 2025 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 25,255 | n/a |
| Feb 19, 2025 | JOHNSON & JOHNSON (JNJ) | Grant/Award | 89,781 | n/a |
| Feb 19, 2025 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 1,350 | n/a |
| May 3, 2024 | JOHNSON & JOHNSON (JNJ) | Exercise/Conversion | 22,255 | n/a |
| Feb 20, 2024 | JOHNSON & JOHNSON (JNJ) | Grant/Award | 65,163 | n/a |